Balyasny Asset Management’s Usana Health Sciences USNA Stock Holding History

Balyasny Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,471	Closed	-$200K	–	3528
2026 Q1	$200K	Sell	11,471 -19,285	-63%	-$383K	﹤0.01%	2706
2025 Q4	$604K	Buy	+30,756	New	+$638K	﹤0.01%	2438
2024 Q1	–	Sell	-13,934	Closed	-$747K	–	3148
2023 Q4	$747K	Buy	+13,934	New	+$705K	﹤0.01%	1801
2023 Q2	–	Sell	-13,091	Closed	-$823K	–	2823
2023 Q1	$823K	Buy	+13,091	New	+$781K	﹤0.01%	1809
2022 Q2	–	Sell	-9,765	Closed	-$776K	–	3210
2022 Q1	$776K	Buy	+9,765	New	+$880K	﹤0.01%	1702
2021 Q3	–	Sell	-8,354	Closed	-$856K	–	2447
2021 Q2	$856K	Buy	8,354 +3,954	+90%	+$397K	﹤0.01%	1358
2021 Q1	$429K	Buy	+4,400	New	+$400K	﹤0.01%	1440
2020 Q1	–	Sell	-22,602	Closed	-$1.77M	–	1543
2019 Q4	$1.77M	Buy	22,602 +7,894	+54%	+$582K	0.01%	778
2019 Q3	$1.01M	Buy	+14,708	New	+$988K	0.01%	833
2019 Q2	–	Sell	-8,225	Closed	-$690K	–	1746
2019 Q1	$690K	Buy	+8,225	New	+$859K	﹤0.01%	1118
2017 Q4	–	Sell	-5,250	Closed	-$303K	–	2337
2017 Q3	$303K	Buy	+5,250	New	+$310K	﹤0.01%	1532

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's USNA Position: Q2 2026 in Review

Balyasny Asset Management sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 11,471 shares — an estimated $200K sold.

Balyasny Asset Management first reported a position in USNA in Q3 2017 and held it in 11 quarters. The position peaked at $1.77M in Q4 2019. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Balyasny Asset Management reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 11,471 Usana Health Sciences shares in Q2 2026, an estimated $200K.
Balyasny Asset Management first reported a position in Usana Health Sciences in Q3 2017 and held it in 11 quarters.
Balyasny Asset Management's Usana Health Sciences position peaked at $1.77M in Q4 2019.
137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.